Novo Holdings Asia's Amit Kakar speaks at the Asia Summit on Global Health in Hong Kong (courtesy HKTDC)

No­vo Hold­ings’ head of Asia on in­vest­ing in ‘Chi­na for Chi­na,’ and stay­ing out of biotech (for now)

Geopo­lit­i­cal head­winds may have giv­en some for­eign life sci­ences in­vestors pause about in­vest­ing in Chi­na. But for No­vo Hold­ings Asia, it’s a good time to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.